Clinigen is a global pharmaceutical and services company with a unique combination of businesses focused on providing ethical access to medicines.
Its mission is to deliver the right medicine, to the right patient, at the right time through three areas of global medicine supply; clinical trial, unlicensed and licensed medicines. The Group has sites in North America, Europe, Africa and Asia Pacific (‘AAA’). Clinigen now has over 1,100 employees across five continents in 14 countries, with supply and distribution hubs and operational centres of excellence in key long-term growth regions. The Group works with 22 of the top 25 pharmaceutical companies; interacting with over 15,000 registered users across over 100 countries, shipping approximately 6.4 million units in the year - View Overview PDF
Clinigen has built a global operating platform that can supply and distribute medicines at the key stages in the pharmaceutical product lifecycle - View Platform PDF
Clinigen proposition has the capability to provide added value to two key customers: pharmaceutical and biotech clients; and HCPs customers - View Proposition PDF
Clinigen has the capability to expand the life and value of a medicine and provide distribution services and solutions in complex regulatory situations - View Product PDF